A new trading day began on Tuesday, with Skye Bioscience Inc (NASDAQ: SKYE) stock price up 30.53% from the previous day of trading, before settling in for the closing price of $1.31. SKYE’s price has ranged from $1.14 to $17.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -64.45%. With a float of $17.94 million, this company’s outstanding shares have now reached $30.97 million.
Let’s look at the performance matrix of the company that is accounted for 16 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Skye Bioscience Inc (SKYE) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Skye Bioscience Inc is 42.09%, while institutional ownership is 42.73%. The most recent insider transaction that took place on Nov 18 ’24, was worth 97,250. In this transaction Chief Development Officer of this company sold 19,489 shares at a rate of $4.99, taking the stock ownership to the 82,259 shares. Before that another transaction happened on Nov 15 ’24, when Company’s Chief Development Officer sold 85 for $5.55, making the entire transaction worth $472. This insider now owns 101,748 shares in total.
Skye Bioscience Inc (SKYE) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -64.45% per share during the next fiscal year.
Skye Bioscience Inc (NASDAQ: SKYE) Trading Performance Indicators
Here are Skye Bioscience Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 16.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.73, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.43 in one year’s time.
Technical Analysis of Skye Bioscience Inc (SKYE)
Skye Bioscience Inc (NASDAQ: SKYE) saw its 5-day average volume 5.61 million, a positive change from its year-to-date volume of 0.57 million. As of the previous 9 days, the stock’s Stochastic %D was 44.57%. Additionally, its Average True Range was 0.39.
During the past 100 days, Skye Bioscience Inc’s (SKYE) raw stochastic average was set at 16.12%, which indicates a significant decrease from 22.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 181.51% in the past 14 days, which was higher than the 119.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.3689, while its 200-day Moving Average is $4.0670. Nevertheless, the first resistance level for the watch stands at $3.1313 in the near term. At $4.5527, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.3783. If the price goes on to break the first support level at $0.8843, it is likely to go to the next support level at $0.0587.
Skye Bioscience Inc (NASDAQ: SKYE) Key Stats
With a market capitalization of 52.97 million, the company has a total of 30,975K Shares Outstanding. Currently, annual sales are 0 K while annual income is -26,570 K. The company’s previous quarter sales were 0 K while its latest quarter income was -9,750 K.
